Skip to main content

ADVERTISEMENT

Drug-eluting stents

Original Contribution
11/25/2018

Ruben Vergara, MD;  Renato Valenti, MD;  Angela Migliorini, MD;  Michele Ciabatti, MD;  Maria Grazia De Gregorio, MD;  Giulia Taborchi, MD;  Sofia Morini, MD;  Roberto Rondine, MD;  Raffaelle Martone, MD;  David Antoniucci, MD

Ruben Vergara, MD;  Renato Valenti, M...
We prospectively analyzed all consecutive patients treated at our center for bifurcation lesions from 2011-2015 and compared the angiographic and clinical outcomes of patients with left main bifurcation lesions vs those with non-left main...
We prospectively analyzed all consecutive patients treated at our center for bifurcation lesions from 2011-2015 and compared the angiographic and clinical outcomes of patients with left main bifurcation lesions vs those with non-left main...
We prospectively analyzed all...
11/25/2018
Journal of Invasive Cardiology
Original Contribution
07/15/2017

Barbara Anna Danek, MD1;  Aris Karatasakis, MD1;  Judit Karacsonyi, MD1;  Waleed Alharbi, MD2;  Michele Roesle, RN, BSN1;  Bavana V. Rangan, BDS, MPH1;  M. Nicholas Burke, MD2;  Subhash Banerjee, MD1; Emmanouil S. Brilakis, MD, PhD1,2

Barbara Anna Danek, MD1;  Aris Karata...
Outcomes with use of lesion-modification strategies in the drug-eluting stent era have received limited study. We conducted a meta-analysis of 22 studies published between 2004-2016 reporting outcomes after use of rotational atherectomy,...
Outcomes with use of lesion-modification strategies in the drug-eluting stent era have received limited study. We conducted a meta-analysis of 22 studies published between 2004-2016 reporting outcomes after use of rotational atherectomy,...
Outcomes with use of...
07/15/2017
Journal of Invasive Cardiology
Original Contribution
06/15/2017

Ana Cristina Seixas, MD, PhD1,2;  Amanda Sousa, MD, PhD1,2;  Jose de Ribamar Costa, Jr, MD, PhD1,2;  Adriana Costa Moreira, MD, PhD1;  Ricardo Costa, MD, PhD1,2;  Lucas Damiani, MS1;  Cant√≠dio Campos Neto, PhD1,2;  Galo Maldonado, MD1,2;  Manuel Cano, MD, PhD1,2;  J. Eduardo Sousa, MD, PhD1,2 

Ana Cristina Seixas, MD, PhD1,2;  Ama...
We sought to assess the outcomes of patients treated with second-generation drug-eluting stent classified according to the updated American College of Cardiology Foundation/American Heart Association/Society for Cardiac Angiography and...
We sought to assess the outcomes of patients treated with second-generation drug-eluting stent classified according to the updated American College of Cardiology Foundation/American Heart Association/Society for Cardiac Angiography and...
We sought to assess the outcomes...
06/15/2017
Journal of Invasive Cardiology
Review
11/01/2015

Nicolas W. Shammas, MD, MS1 and Subhash Banerjee, MD2

Nicolas W. Shammas, MD, MS1 and Subha...
An overview of the pros and cons of primary stenting of femoropopliteal (FP) arteries vs alternative approaches including provisional stenting following POBA, atherectomy and/or drug-coated balloons.
An overview of the pros and cons of primary stenting of femoropopliteal (FP) arteries vs alternative approaches including provisional stenting following POBA, atherectomy and/or drug-coated balloons.
An overview of the pros and cons...
11/01/2015
Journal of Invasive Cardiology
10/01/2015

N. Boopathy Senguttuvan, MD;  Sharif Ellozy, MD;  Furqan Tejani, MD;  Jason Kovacic, MD;  Annapoorna S. Kini, MD;  Samin K. Sharma, MD;  George D. Dangas, MD

N. Boopathy Senguttuvan, MD;  Sharif ...
An 86-year-old Caucasian female with severe symptomatic, inoperable aortic stenosis was accepted for high-risk transfemoral TAVR due to severe calcification of the aorta. The authors utilized the elevator technique, which allows axial...
An 86-year-old Caucasian female with severe symptomatic, inoperable aortic stenosis was accepted for high-risk transfemoral TAVR due to severe calcification of the aorta. The authors utilized the elevator technique, which allows axial...
An 86-year-old Caucasian female...
10/01/2015
Journal of Invasive Cardiology
Commentary
07/30/2015

Gerald Dorros, MD, ScD 

Gerald Dorros, MD, ScD 
Dr Dorros warns that in the current health-care climate, cardiologists face the danger of becoming mere technocrats, employed and dictated to by health-care executives, whose main focus is the financial bottom line. Cardiologists must remain...
Dr Dorros warns that in the current health-care climate, cardiologists face the danger of becoming mere technocrats, employed and dictated to by health-care executives, whose main focus is the financial bottom line. Cardiologists must remain...
Dr Dorros warns that in the...
07/30/2015
Journal of Invasive Cardiology
Original Contribution
07/30/2015

Joon-Hyung Doh, MD, PhD1,2;  Chang-Wook Nam, MD, PhD3;  Bon-Kwon Koo, MD, PhD4;  Sung Yun Lee, MD, PhD1; Hyunmin Choi, MD1;  June Namgung, MD, PhD1;  Sung Uk Kwon, MD, PhD1;  Jae-Jin Kwak, MD1; Hyung-Yoon Kim, MD1;  Won-Ho Choi, MD1;  Won Ro Lee, MD, PhD1

Joon-Hyung Doh, MD, PhD1,2;  Chang-Wo...
The prognostic value of poststent fractional flow reserve (FFR) has not been clearly defined in patients with DES implantation. This study evaluates the association between FFR and clinical outcomes after DES implantation with IVUS...
The prognostic value of poststent fractional flow reserve (FFR) has not been clearly defined in patients with DES implantation. This study evaluates the association between FFR and clinical outcomes after DES implantation with IVUS...
The prognostic value of...
07/30/2015
Journal of Invasive Cardiology
Letters to the Editor
02/01/2015

Richard R. Heuser, MD

 
Richard R. Heuser, MD  
Dr Heuser reflects on the evolution of coronary aneurysm treatment, from his experience as part of the team that place the first PTFE-covered stent in 1993, to today.
Dr Heuser reflects on the evolution of coronary aneurysm treatment, from his experience as part of the team that place the first PTFE-covered stent in 1993, to today.
Dr Heuser reflects on the...
02/01/2015
Journal of Invasive Cardiology
Commentary
11/26/2014

Ganesh Athappan, MD and Samin K. Sharma, MD

Ganesh Athappan, MD and Samin K. Shar...
The authors provide their thoughts on the current state of bifurcation interventions. Despite the advances in stent technology and catheter techniques, bifurcation lesions present a formidable challenge to the interventional cardiologist...
The authors provide their thoughts on the current state of bifurcation interventions. Despite the advances in stent technology and catheter techniques, bifurcation lesions present a formidable challenge to the interventional cardiologist...
The authors provide their...
11/26/2014
Journal of Invasive Cardiology
Original Contribution
11/26/2014

Miroslaw Ferenc, MD1;  Ran Kornowski, MD2;  Jorge Belardi, MD3;  Patrick Serruys, MD, PhD4;  Sigmund Silber, MD5;  Petr Widimsk√Ω, MD6;  Stephan Windecker, MD7;  Franz-Josef Neumann, MD1

Miroslaw Ferenc, MD1;  Ran Kornowski,...
We investigate the outcomes of percutaneous coronary intervention (PCI) in bifurcation versus non-bifurcation lesions using the next-generation Resolute zotarolimus-eluting stent. There was an increased risk associated with bifurcation...
We investigate the outcomes of percutaneous coronary intervention (PCI) in bifurcation versus non-bifurcation lesions using the next-generation Resolute zotarolimus-eluting stent. There was an increased risk associated with bifurcation...
We investigate the outcomes of...
11/26/2014
Journal of Invasive Cardiology